SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer.
Karagas MR, Andrew AS, Nelson HH, Li Z, Punshon T, Schned A, Marsit CJ, Morris JS, Moore JH, Tyler AL, Gilbert-Diamond D, Guerinot ML, Kelsey KT.
Karagas MR, et al. Among authors: nelson hh.
Hum Genet. 2012 Mar;131(3):453-61. doi: 10.1007/s00439-011-1090-x. Epub 2011 Sep 25.
Hum Genet. 2012.
PMID: 21947419
Free PMC article.